Intelligent Bio Solutions Inc. (INBS) recently announced positive initial results from its Pharmacokinetic (PK) study. The study is important for supporting FDA 510(k) clearance of the company’s Intelligent Fingerprinting Drug Screening technology.Per the PK study's data, the amount and rate of codeine in blood and saliva are mimicked by fingerprint sweat. Based on 95% confidence level statistical comparisons, the study effectively demonstrated that fingerprint sweat offers a dependable sample matrix for dr ...